Sobr Safe Inc
TransBiotec Inc
Price sits at 11% of its 52-week range.
Current Price
$0.98
+79.87%GoodMoat Value
$1.89
92.9% undervaluedSobr Safe Inc (SOBR) Financial Statements
SOBR Computed Insights
Income Statement
Balance Sheet
Cash Flow Statement
SOBR Financial Statements & Data
Sobr Safe Inc (SOBR) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Sobr Safe Inc's financial performance and position as a Technology company.
Trailing twelve-month (TTM) revenue is $429807.00. Gross profit (TTM) is $229455.00. EBITDA is $-8.87M. Earnings per share (EPS) is $-6.12. The P/E ratio is -0.16. Market capitalization is $1.49M.
Free cash flow (FCF) is $-7.00M. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 6 years from FY20 to FY25. Net income history spans 6 years. Free cash flow and capital expenditure data spans 6 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Sobr Safe Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.